Ocular Therapeutix (OCUL) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts OCUL Hot Sheet
Join SI Premium – FREE
Ocular Therapeutix (NASDAQ: OCUL) reported Q2 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49).
For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is the global equity rally broadening? UBS weighs in
- Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
- The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
